Our lung cancer models indicate that imposition of Myc hypomorphism prior to KRasG12D activation is highly protective against the evolution of invasive lung cancer, forestalling the transition from indolent hyperplasia to invasive disease. This evidence concerns the gene MYC and lung cancer.